FUNCTIONAL-CHARACTERIZATION OF SUBSTANCE-P RECEPTORS ON CULTURED HUMAN SPINAL-CORD ASTROCYTES - SYNERGISM OF SUBSTANCE-P WITH CYTOKINES IN INDUCING INTERLEUKIN-6 AND PROSTAGLANDIN E-2 PRODUCTION
C. Palma et al., FUNCTIONAL-CHARACTERIZATION OF SUBSTANCE-P RECEPTORS ON CULTURED HUMAN SPINAL-CORD ASTROCYTES - SYNERGISM OF SUBSTANCE-P WITH CYTOKINES IN INDUCING INTERLEUKIN-6 AND PROSTAGLANDIN E-2 PRODUCTION, Glia, 21(2), 1997, pp. 183-193
Following brain injury, astrocytes express receptors for cytokines and
neuropeptides and secrete several regulatory mediators that have a we
ll established role in inflammation, immunity, and tissue development
or repair. To elucidate the role of substance P (SP), a neurotransmitt
er peptide of the tachykinin family, in inducing astrocyte secretory a
ctivities, we have examined the expression of SP receptors and the fun
ctional consequences of their activation in cultured astrocytes from t
he human embryonic brain or spinal cord. Radioligand binding studies r
evealed that only one type of SP receptors, the high affinity NK-1 rec
eptor, was present on human astrocytes and that spinal cord astrocytes
expressed about 6 times as many SP binding sites as brain astrocytes.
Following SP treatment, a substantial inositol phosphate formation wa
s observed in spinal cord astrocytes only. Stimulation of spinal cord
astrocytes with SP alone did not induce secretion of cytokines [interl
eukin-6 (IL-6), granulocyte-macrophage-CSF, macrophage chemoattractant
protein-1 or leukemia inhibitory factor] or prostaglandin E-2 (PGE(2)
). Interestingly, however, SP selectively potentiated the inducing eff
ect of IL-1 beta on IL-6 and PGE(2) secretion by spinal cord astrocyte
s without affecting the IL-1-beta-evoked secretion of other cytokines.
SP also enhanced the small inducing effect of tumor necrosis factor-a
lpha (TNF-alpha) on IL-6 and PGE(2) secretion and that of transforming
growth factor-beta on PGE(2) secretion. These results suggest that SP
can enhance immunoregulatory and neurotrophic astroglial functions me
diated by IL-6 and PGE(2) by acting in concert with a set of cytokines
whose cerebral expression has been reported during development and in
a variety of diseases. (C) 1997 Wiley-Liss, Inc.